PLX

Protalix BioTherapeutics Inc

Jun 17 • 12:06PM ET

2.06

-0.00 -0.24 %

Healthcare • Biotechnology • USA • Micro • AMEX

Peers: ANTX BDTX TNYA MOLN HURA MENS MSLE OKUR ORMP SPRB

Scroll to Statements

Index	RUT	P/E	11.21	EPS (ttm)	0.18	Insider Own	3.88%	Shs Outstand	80.57M	Perf Week	4.31%
Market Cap	165.58M	Forward P/E	41.10	EPS next Y	0.05	Insider Trans	1.82%	Shs Float	77.45M	Perf Month	7.59%
Enterprise Value	122.27M	PEG	-	EPS next Q	-0.01	Inst Own	22.04%	Short Float	5.08%	Perf Quarter	-7.01%
Income	15.33M	P/S	2.17	EPS this Y	343.75%	Inst Trans	-9.81%	Short Ratio	4.88	Perf Half Y	18.10%
Sales	76.38M	P/B	2.46	EPS next Y	-74.36%	ROA	17.40%	Short Interest	3.94M	Perf YTD	14.17%
Book/sh	0.83	P/C	3.20	EPS next 5Y	-	ROE	27.27%	52W High	3.19 -35.58%	Perf Year	50.00%
Cash/sh	0.64	P/FCF	12.74	EPS past 3/5Y	35.12% 17.78%	ROIC	20.64%	52W Low	1.32 55.68%	Perf 3Y	-4.42%
Dividend Est.	-	EV/EBITDA	5.74	Sales past 3/5Y	3.45% -3.46%	Gross Margin	69.97%	Volatility	3.33% 3.83%	Perf 5Y	0.24%
Dividend TTM	-	EV/Sales	1.60	EPS Y/Y TTM	268.45%	Oper. Margin	25.91%	ATR (14)	0.08	Perf 10Y	-72.60%
Dividend Ex-Date	-	Quick Ratio	2.04	Sales Y/Y TTM	27.80%	Profit Margin	20.07%	RSI (14)	50.87	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.15	EPS Q/Q	567.37%	SMA20	0.62%	Beta	0.02	Target Price	11.00
Payout	-	Debt/Eq	0.13	Sales Q/Q	233.73%	SMA50	-1.77%	Rel Volume	1.10	Prev Close	2.06
Employees	226	LT Debt/Eq	0.10	Earnings	May 13 BMO	SMA200	-5.41%	Avg Volume	806.30K	Price	2.06
IPO	Apr 09, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	2300.00% 193.48%	Trades		Volume	381,472	Change	-0.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)